Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

65--Notice of Intent of Award Carticel cell & Implantation system

Active
W91YU0T139377Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The U.S. Army Medical Command (MEDCOM), Western Regional Contracting Office in Tacoma, Washington, plans to award a firm-fixed price contract valued at $35,000 to US Bioservices for the Carticel cell and implantation system. This procurement aligns with FAR Subpart 13.106-1(b)(1) and will utilize simplified acquisition procedures as outlined in FAR Part 13. The selected product must be FDA-approved and meet the specific medical requirements determined by the Surgeon for the patient’s needs. The contract is intended to ensure the best available medical solution for the patient, based on professional medical assessment. This announcement is not a solicitation and no formal request for proposal will be issued. However, other suppliers interested in providing similar supplies or equipment may submit information demonstrating their capabilities and product specifications for consideration in future requirements. All responses must be directed to the designated purchasing agent via email only, with no phone or fax communications accepted. This approach allows the contracting office to maintain a pool of qualified vendors for upcoming acquisitions related to similar medical devices.

General Info

$35,000 contract awarded to US Bioservices for FDA-approved Carticel cell implantation system.

Agency

N/A

NAICS

446110 - Pharmacies and Drug Stores

Place of Performance

Not specified

Set-Aside

NONE

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

special-notice

Ready to pursue this opportunity?

Get full access to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyN/A
ContactsNo contacts available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Pursuant to FAR Subpart 13.106-1(b)(1), the U.S. Army, MEDCOM, Western Regional Contracting(WRCO), Tacoma, WA, intends to issue a firm-fixed price award to US Bioservices for their Carticel cell & Implantation system in the amount of $35,000.00. The Surgeon has determined that these products will best meet the patient's specific medical needs/requirements. ALL PRODUCTS MUST BE FDA APPROVED and meet the surgeons' and the patients' specific medical needs/requirements. Interested persons may identify their interest and capability to respond to future requirements. This notice is not a request for proposal and no solicitation will be issued. Any firm that believes it can provide the stated supplies/equipment can provide supporting documents demonstrating their products capability and specifications. Responses received will be used for future acquisitions. Information can be sent to the Purchasing Agent Ms. Jenni Lundquist contact@example.gov. No telephone or facsimile requests will be accepted. This procurement will be prepared in accordance with FAR Part 13, using Simplified Acquisition Procedures.

Similar Contracts

Same NAICS industry code

NAICS: 446110
Federal
Specialty Pharmacy Fulfillment of Lenalidomide (Revlimid)The contract involves the specialty pharmacy fulfillment and delivery of Lenalidomide (Revlimid), a medication used primarily in the treatment of certain cancers and blood disorders, to patients of the Department of Veterans Affairs (VA). The contractor is responsible for dispensing either branded or therapeutically equivalent versions of Lenalidomide in varying strengths. This service must comply with Risk Evaluation and Mitigation Strategies (REMS) protocols, ensuring safe and effective use of the medication. Essential contract activities include verifying prescriptions, conducting patient outreach to support medication adherence and understanding, securely packaging the medication, and ensuring delivery is confirmed by obtaining signatures upon receipt. This subcontract is issued by the 252-NETWORK Contract Office 12 under the Department of Veterans Affairs and aligns with NAICS code 446110, which typically covers pharmacies and drug stores. While specific performance location details and points of contact are not provided, the contract underscores the importance of compliance with federal safety standards and thorough patient management. The seamless coordination of prescription verification, patient communication, packaging, and secure delivery highlights the contractor’s critical role in supporting VA patients’ access to this specialized pharmaceutical therapy.
252-NETWORK Contract Office 12 (36C252)

POSTED

10 months ago

DEADLINE

N/A
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS